Literature DB >> 9202406

MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response.

M W Kilgore1, P L Tate, S Rai, E Sengoku, T M Price.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors that regulate transcription of target genes. Since attempts have been made to correlate the ingestion of high-fat diets, itself a peroxisome proliferator, with the occurrence of breast cancer, we set about to determine if human breast cancer cells contained a functional PPAR. In this report we demonstrate the presence of an mRNA in two breast cancer cell lines (MCF-7 and T47D) which is specifically recognized by a mouse PPARgamma2 probe. Furthermore, in gel shift assays a consensus PPAR response element (PPRE) was specifically bound by nuclear extracts from MCF-7 cells and was further retarded by antibodies raised to mouse PPARgamma. Finally, when transfected with a PPRE-luciferase transcriptional reporter construct, transcription was increased in response to activators of PPAR and its dimmeric partner the retinoic acid X receptor (RXR). These data indicate that peroxisomal proliferators are capable of mediating transcription in human breast cells and suggest the possibility of a physiological role in the breast.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202406     DOI: 10.1016/s0303-7207(97)04057-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

Authors:  Chuanbing Zang; Marlies Wächter; Hongyu Liu; Maximilian G Posch; Martin H Fenner; Christine Stadelmann; Andreas von Deimling; Kurt Possinger; Keith L Black; H Phillip Koeffler; Elena Elstner
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

2.  Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.

Authors:  Nina Ditsch; Doris Mayr; Miriam Lenhard; Carolin Strauss; Andrea Vodermaier; Julia Gallwas; Doris Stoeckl; Monika Graeser; Tobias Weissenbacher; Klaus Friese; Udo Jeschke
Journal:  Oncol Lett       Date:  2012-07-13       Impact factor: 2.967

3.  MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells.

Authors:  Xin Wang; R Chase Southard; Clinton D Allred; Dominique R Talbert; Melinda E Wilson; Michael W Kilgore
Journal:  Breast Cancer Res Treat       Date:  2007-09-28       Impact factor: 4.872

4.  Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

Authors:  E Elstner; C Müller; K Koshizuka; E A Williamson; D Park; H Asou; P Shintaku; J W Said; D Heber; H P Koeffler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

5.  The nuclear oxysterol receptor LXRalpha is expressed in the normal human breast and in breast cancer.

Authors:  D M Vigushin; Y Dong; L Inman; N Peyvandi; J P Alao; C Sun; S Ali; E J Niesor; C L Bentzen; R C Coombes
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

6.  Mechanisms Mediating the Effects of γ-Tocotrienol When Used in Combination with PPARγ Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer Cells.

Authors:  Abhita Malaviya; Paul W Sylvester
Journal:  Int J Breast Cancer       Date:  2013-01-28

7.  Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.

Authors:  Ji Seung Han; David L Crowe
Journal:  BMC Cancer       Date:  2010-11-16       Impact factor: 4.430

Review 8.  Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?

Authors:  R L Melnick
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

9.  Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.

Authors:  Yekaterina Y Zaytseva; Xin Wang; R Chase Southard; Natalie K Wallis; Michael W Kilgore
Journal:  Mol Cancer       Date:  2008-12-05       Impact factor: 27.401

10.  A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.

Authors:  David L Crowe; Roshantha A S Chandraratna
Journal:  Breast Cancer Res       Date:  2004-07-23       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.